Home › Cases › Day Eight, and the Broad-Spectrum Question
Hospital-Acquired Pneumonia
Day Eight, and the Broad-Spectrum Question
6 questions
Question 1 · The decision
Correct answer: Whether she is at higher risk of a resistant organism
Why
Severity matters, but the higher-resistance-risk question is the one the pathway is built around — it is what separates co-amoxiclav from piperacillin-tazobactam.
She triggers it twice over: onset more than 5 days after admission, and recent broad-spectrum antibiotics. Either alone would be enough.
CURB-65 is for CAP and will mislead you here. There is no validated severity score for HAP — severity is clinical judgement.
Key point
The antibiotic follows the resistance risk, not a severity score. CURB-65 is for CAP.
Question 2 · The five triggers
Correct answer: Age over 75 with two or more comorbidities
Why
The five are: onset more than 5 days after admission, severe lung disease or immunosuppression, recent broad-spectrum antibiotics, known MDR colonisation, and recent health or social care contact before this admission.
Age and comorbidity count towards how unwell someone is and how they will tolerate it — but they do not predict a resistant organism, and treating them as though they do sends every frail patient straight to a carbapenem.
Key point
Five triggers: >5 days · severe lung disease or immunosuppression · recent broad-spectrum · known MDR · recent care contact.
Question 3 · What to send
Correct answer: A respiratory sample — sputum, nasopharyngeal swab or tracheal aspirate
Why
A respiratory sample is routine in HAP, unlike CAP. That is the whole reason you can narrow the antibiotic at day 5 — and narrowing is the point of having sent it.
Urinary antigens are CAP tests. Procalcitonin has a place at day 3–4 if you are worried about failure, not as a gate on starting.
Also: blood cultures if septic, and the usual bloods and a gas.
Key point
The respiratory sample is routine in HAP. Send it, then use it to narrow.
Question 4 · Choosing
Correct answer: IV therapy on microbiological advice — piperacillin-tazobactam 4.5g TDS would be a typical choice — and check the local antimicrobial policy
Why
Higher resistance risk means IV, on microbiology advice. Piperacillin-tazobactam 4.5g TDS is one of the named options, alongside ceftazidime, ceftriaxone, cefuroxime and meropenem.
Starting at meropenem because it is broadest is exactly what the pathway asks you to weigh against: the C. difficile risk of broad-spectrum cover is why this is not automatic, particularly in a 77-year-old who has already had co-amoxiclav.
And local antimicrobial policy outranks every drug named in the app.
Key point
IV on microbiology advice, weighing C. difficile risk. Local policy outranks the app.
Question 5 · The clock
Correct answer: Within 4 hours
Why
Antibiotics within 4 hours for HAP.
The one-hour clock belongs to sepsis — and if she is septic, you run the sepsis pathway alongside this one and NEWS2 sets the antibiotic clock. Her NEWS2 of 6 is worth taking seriously on exactly that basis.
Waiting 24 hours for a culture is never the trade. Send the sample, then treat.
Key point
4 hours for HAP, but if septic the sepsis clock wins and NEWS2 sets it.
Question 6 · Day five
Correct answer: Review at 5 days, narrow to the sensitivities, switch IV to oral where severity allows, and consider stopping if she is clinically stable
Why
Review at 5 days and consider stopping if clinically stable. IV to oral by 48 hours where severity allows — she is past that already. Narrow when the sample result lands; that is why you sent it.
Fixed course lengths and CRP-chasing both keep people on broad-spectrum antibiotics past the point of benefit, which is the behaviour the C. difficile warning exists to discourage.
Key point
Review at 5 days. Narrow to the sample. IV to oral by 48 hours. Stop if stable.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.